EBV Viral Capsid Antigen IgG Interpretation

Introduction to EBV Infection

The presence of EBV viral capsid antigen (VCA) IgG indicates past exposure to Epstein-Barr virus and typically requires no treatment or further evaluation in asymptomatic individuals 1
VCA IgG positivity demonstrates immunity from previous EBV infection, which persists for life after initial exposure 1

When VCA IgG is present without accompanying IgM antibodies, this pattern indicates past infection rather than acute or recent infection 1
The American Journal of Hematology suggests that markedly elevated VCA IgG titers (≥1:640) combined with elevated anti-EA IgG (≥1:160) should be considered for Chronic Active EBV Infection (CAEBV) 3, 4
Persistent or recurrent infectious mononucleosis-like symptoms (fever, lymphadenopathy, hepatosplenomegaly) may indicate CAEBV 3, 4

The American College of Physicians may recommend no treatment needed for asymptomatic patients with positive VCA IgG 1
For symptomatic patients with positive VCA IgG, assess symptom duration and severity (fever, lymphadenopathy, hepatosplenomegaly) 3, 4
If symptoms persist >10 days or are severe, order complete EBV antibody panel including VCA IgM, EBNA, and EA antibodies with titers 4, 2

Patients with CAEBV have poor prognosis, particularly with late disease onset, thrombocytopenia, and EBV infection of T cells 3
Some CAEBV patients develop oligoclonal or monoclonal lymphoproliferation, eventually progressing to T-cell or NK-cell malignant lymphomas 4
Aggressive immunomodulatory therapy or stem cell transplantation may be necessary in severe cases 4